159 related articles for article (PubMed ID: 35092398)
1. The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma.
Lee MJ; Kim D
Asian Pac J Cancer Prev; 2022 Jan; 23(1):281-285. PubMed ID: 35092398
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.
Chen S; Wang LL; Sun KX; Liu Y; Guan X; Zong ZH; Zhao Y
Cell Physiol Biochem; 2018; 47(4):1578-1588. PubMed ID: 29949791
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts.
Kim DK; Kim EK; Jung DW; Kim J
PLoS One; 2019; 14(3):e0214553. PubMed ID: 30921404
[TBL] [Abstract][Full Text] [Related]
4. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract][Full Text] [Related]
5. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
6. Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis.
Li S; Li C; Zhang Y; He X; Chen X; Zeng X; Liu F; Chen Y; Chen J
Theranostics; 2019; 9(17):4993-5008. PubMed ID: 31410197
[TBL] [Abstract][Full Text] [Related]
7. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
8. Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway.
Li Z; Lian Z; Ma J; Zhang L; Lian X; Liu S; Xie J; Feng Z; Lin T; Zhang H; Liang X
Bioengineered; 2021 Dec; 12(1):1138-1149. PubMed ID: 33818281
[TBL] [Abstract][Full Text] [Related]
9. RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo.
Alkasalias T; Alexeyenko A; Hennig K; Danielsson F; Lebbink RJ; Fielden M; Turunen SP; Lehti K; Kashuba V; Madapura HS; Bozoky B; Lundberg E; Balland M; Guvén H; Klein G; Gad AK; Pavlova T
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1413-E1421. PubMed ID: 28174275
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
11. Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance.
Levesque C; Nelson PS
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 28490538
[TBL] [Abstract][Full Text] [Related]
12. YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts.
Shen T; Li Y; Wang D; Su Y; Li G; Shang Z; Niu Y; Tan X
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166540. PubMed ID: 36100154
[TBL] [Abstract][Full Text] [Related]
13. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy.
Zhang W; Han H
Exp Eye Res; 2021 Aug; 209():108677. PubMed ID: 34147507
[TBL] [Abstract][Full Text] [Related]
14. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
[TBL] [Abstract][Full Text] [Related]
15. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
[TBL] [Abstract][Full Text] [Related]
16. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
Wei X; Lou H; Zhou D; Jia Y; Li H; Huang Q; Ma J; Yang Z; Sun C; Meng Y; Xu S; Yang X; Li X; Ji T; Guo Z; Gao Q
J Exp Clin Cancer Res; 2021 Sep; 40(1):292. PubMed ID: 34538264
[TBL] [Abstract][Full Text] [Related]
17. CD44 acts through RhoA to regulate YAP signaling.
Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
[TBL] [Abstract][Full Text] [Related]
18. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.
Orr B; Riddick AC; Stewart GD; Anderson RA; Franco OE; Hayward SW; Thomson AA
Oncogene; 2012 Mar; 31(9):1130-42. PubMed ID: 21804603
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
20. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
